Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Hahakdogon Jan 19, 2021 3:10pm
104 Views
Post# 32328419

A Potential Trillion Dollar Industry

A Potential Trillion Dollar Industry
 
Sponsored post
 
The global tobacco market was estimated by approximately USD $814 billion in 2018. Approximately 1.3 billion people
worldwide use tobacco in some form.
 
With several hundred million legal-aged smokers worldwide, there is tremendous possibility for a nicotine-free and tobacco-free product. Unlike alternatives such as vaping, these other companies offers a substantially similar user experience as a combustible product.
 
Check disclaimer on profile and landing page
<< Previous
Bullboard Posts
Next >>